Stock Attack -- A Complete Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Attack -- A Complete Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chris who wrote (4315)	12/23/1997 11:14:00 PM
From: Arthur Radley	Read Replies (1) of 42787

Chris, I am a first timer to your thread and would like your opinion on a stock that I have great faith in but there is one issue overhanging it that caused a recent drop in the share price. The stock is Polymedica(PM)and is in the growing field of diabetic supplies. Their 6 months revenue has already exceeded last years full 12 months. This has been accomplished with a unique and only national TV campaign(Lauren Bacall is spokesperson in ads)to supply diabetic supplies to people that are insulin dependent. On July 1, 1998 nearly 2 million people that are not insulin dependent will be covered under Medicare reimbursement for testing for diabetes. Even without these potential customers PM has increased their patient count by 200% in less than a year. My question is the issue of how they account for their advertising cost. Currently and approved by their accountants(Coopers and Lybrand(SP)they are spreading it out over 7 years. A recent WSJ article questioned this arrangement and caused the stock to drop back to the $10.00 level. Do you have any experience with this issue? Thanks for your input.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next